Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gestational trophoblastic neoplasms.

R D Hilgers, J L Lewis

    Gynecologic Oncology
    |December 1, 1974
    PubMed
    Summary
    This summary is machine-generated.

    Gestational trophoblastic neoplasms are successfully treated with chemotherapy. High-risk patients benefit from initial combination chemotherapy and adjuvant therapies for better outcomes.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Past, present and future of gestational trophoblastic diseases.

    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics·2018
    Same author

    Disinfection of gloves: feasible, but pay attention to the disinfectant/glove combination.

    The Journal of hospital infection·2016
    Same author

    Development and utility of the FDA 'GutProbe' DNA microarray for identification, genotyping and metagenomic analysis of commercially available probiotics.

    Journal of applied microbiology·2015
    Same author

    Effects of association and repetition in memory for temporal order.

    Memory & cognition·2013
    Same author

    Kiss1 and Kiss1r mRNA expression in the rat placenta: changes with gestational age and regulation by glucocorticoids.

    Placenta·2013
    Same author

    The inflammatory state of the rat placenta increases in late gestation and is further enhanced by glucocorticoids in the labyrinth zone.

    Placenta·2013
    Same journal

    Toward precision prognosis: Predicting recurrence-free survival in high-grade serous ovarian cancer patients using multi-time point clinical and computed tomography radiomics data.

    Gynecologic oncology·2026
    Same journal

    Adjunctive sodium-glucose cotransporter 2 (SGLT2) inhibitors with progestins and endometrial cancer risk in benign uterine diseases and hyperplasia.

    Gynecologic oncology·2026
    Same journal

    Updated patient-reported outcomes and the effect of disease progression on health-related quality of life in the PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer.

    Gynecologic oncology·2026
    Same journal

    PRO-PLATINUM: A randomized, double-blind, placebo controlled study to investigate the efficacy of a probiotic intervention on the gut and vaginal microbiome of ovarian cancer patients undergoing treatment with platinum chemotherapy.

    Gynecologic oncology·2026
    Same journal

    A second chance for the second look: Feasibility of laparoscopic HIPEC at the conclusion of upfront treatment for epithelial ovarian cancer.

    Gynecologic oncology·2026
    Same journal

    Prognostic impact of time to first recurrence in low-grade serous ovarian carcinoma: A multicentric retrospective study from the French TMRG network.

    Gynecologic oncology·2026
    See all related articles

    Area of Science:

    • Gynecology
    • Oncology
    • Reproductive Medicine

    Background:

    • Gestational trophoblastic neoplasms (GTNs) encompass a spectrum of placental-related tumors.
    • Chemotherapy has revolutionized GTN treatment, improving patient survival rates.
    • Accurate diagnosis and risk stratification are crucial for effective GTN management.

    Purpose of the Study:

    • To review the classification, biological behavior, clinical diagnosis, and treatment of GTNs.
    • To highlight advancements in chemotherapy and adjuvant therapies for GTNs.
    • To discuss the role of human chorionic gonadotropin (HCG) in diagnosis and monitoring.

    Main Methods:

    • Review of existing literature on GTN classification, diagnosis, and treatment.
    • Analysis of treatment outcomes, particularly with chemotherapy.

    Related Experiment Videos

  • Discussion of diagnostic markers, including human chorionic gonadotropin (HCG).

    • Main Results:

    • Chemotherapy is a successful therapeutic modality for GTNs.
    • High-risk GTN patients (e.g., elevated HCG, metastasis) can be successfully managed with initial combination chemotherapy and adjuvant measures.
    • Human chorionic gonadotropin (HCG) is essential for diagnosis and management, with advancements in beta-subunit detection.

    Conclusions:

    • Gestational trophoblastic neoplasms require a multidisciplinary approach involving chemotherapy and adjuvant therapies.
    • Accurate HCG measurement is critical for diagnosing and monitoring GTNs.
    • Advances in diagnostic techniques and treatment strategies continue to improve outcomes for GTN patients.